The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukemia, Promyelocytic, Acute

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukemia, Promyelocytic, Acute


High impact information on Leukemia, Promyelocytic, Acute


Chemical compound and disease context of Leukemia, Promyelocytic, Acute


Biological context of Leukemia, Promyelocytic, Acute


Anatomical context of Leukemia, Promyelocytic, Acute


Gene context of Leukemia, Promyelocytic, Acute


Analytical, diagnostic and therapeutic context of Leukemia, Promyelocytic, Acute



  1. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. Clarke, N., Jimenez-Lara, A.M., Voltz, E., Gronemeyer, H. EMBO J. (2004) [Pubmed]
  2. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Westervelt, P., Brown, R.A., Adkins, D.R., Khoury, H., Curtin, P., Hurd, D., Luger, S.M., Ma, M.K., Ley, T.J., DiPersio, J.F. Blood (2001) [Pubmed]
  3. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Douer, D., Estey, E., Santillana, S., Bennett, J.M., Lopez-Bernstein, G., Boehm, K., Williams, T. Blood (2001) [Pubmed]
  4. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Goldberg, M.A., Ginsburg, D., Mayer, R.J., Stone, R.M., Maguire, M., Rosenthal, D.S., Antin, J.H. Blood (1987) [Pubmed]
  5. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Bocchia, M., Wentworth, P.A., Southwood, S., Sidney, J., McGraw, K., Scheinberg, D.A., Sette, A. Blood (1995) [Pubmed]
  6. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M.L., Nervi, C., Bozzoni, I. Cell (2005) [Pubmed]
  7. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice. Lane, A.A., Ley, T.J. Cell (2003) [Pubmed]
  8. The role of PML in tumor suppression. Salomoni, P., Pandolfi, P.P. Cell (2002) [Pubmed]
  9. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A., Pandolfi, P.P., Warrell, R.P. N. Engl. J. Med. (1998) [Pubmed]
  10. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR{alpha} blockade in the pathogenesis of acute promyelocytic leukemia. Matsushita, H., Scaglioni, P.P., Bhaumik, M., Rego, E.M., Cai, L.F., Majid, S.M., Miyachi, H., Kakizuka, A., Miller, W.H., Pandolfi, P.P. J. Exp. Med. (2006) [Pubmed]
  11. Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. Longo, L., Pandolfi, P.P., Biondi, A., Rambaldi, A., Mencarelli, A., Lo Coco, F., Diverio, D., Pegoraro, L., Avanzi, G., Tabilio, A. J. Exp. Med. (1990) [Pubmed]
  12. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. Rigas, J.R., Francis, P.A., Muindi, J.R., Kris, M.G., Huselton, C., DeGrazia, F., Orazem, J.P., Young, C.W., Warrell, R.P. J. Natl. Cancer Inst. (1993) [Pubmed]
  13. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. Park, D.J., Chumakov, A.M., Vuong, P.T., Chih, D.Y., Gombart, A.F., Miller, W.H., Koeffler, H.P. J. Clin. Invest. (1999) [Pubmed]
  14. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Koyama, T., Shibakura, M., Ohsawa, M., Kamiyama, R., Hirosawa, S. Blood (1998) [Pubmed]
  15. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells. Estrov, Z., Manna, S.K., Harris, D., Van, Q., Estey, E.H., Kantarjian, H.M., Talpaz, M., Aggarwal, B.B. Blood (1999) [Pubmed]
  16. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts. Testa, U., Grignani, F., Samoggia, P., Zanetti, C., Riccioni, R., Lo Coco, F., Diverio, D., Felli, N., Passerini, C.G., Grell, M., Pelicci, P.G., Peschle, C. J. Clin. Invest. (1998) [Pubmed]
  17. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha. Walter, M.J., Park, J.S., Ries, R.E., Lau, S.K., McLellan, M., Jaeger, S., Wilson, R.K., Mardis, E.R., Ley, T.J. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  18. Precise localization of NF1 to 17q11.2 by balanced translocation. Ledbetter, D.H., Rich, D.C., O'Connell, P., Leppert, M., Carey, J.C. Am. J. Hum. Genet. (1989) [Pubmed]
  19. Differentiation-linked expression of cell surface markers on HL-60 leukemic cells. Boss, M.A., Delia, D., Robinson, J.B., Greaves, M.F. Blood (1980) [Pubmed]
  20. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Licht, J.D., Chomienne, C., Goy, A., Chen, A., Scott, A.A., Head, D.R., Michaux, J.L., Wu, Y., DeBlasio, A., Miller, W.H. Blood (1995) [Pubmed]
  21. All-trans retinoic acid and cyclic adenosine monophosphate cooperate in the expression of leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Gianní, M., Terao, M., Norio, P., Barbui, T., Rambaldi, A., Garattini, E. Blood (1995) [Pubmed]
  22. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Turhan, A.G., Lemoine, F.M., Debert, C., Bonnet, M.L., Baillou, C., Picard, F., Macintyre, E.A., Varet, B. Blood (1995) [Pubmed]
  23. G-CSF signaling can differentiate promyelocytes expressing a defective retinoic acid receptor: evidence for divergent pathways regulating neutrophil differentiation. Maun, N.A., Gaines, P., Khanna-Gupta, A., Zibello, T., Enriquez, L., Goldberg, L., Berliner, N. Blood (2004) [Pubmed]
  24. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Westervelt, P., Lane, A.A., Pollock, J.L., Oldfather, K., Holt, M.S., Zimonjic, D.B., Popescu, N.C., DiPersio, J.F., Ley, T.J. Blood (2003) [Pubmed]
  25. The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cells. Mohri, H., Katoh, K., Iwamatsu, A., Okubo, T. Exp. Cell Res. (1996) [Pubmed]
  26. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Kakizuka, A., Miller, W.H., Umesono, K., Warrell, R.P., Frankel, S.R., Murty, V.V., Dmitrovsky, E., Evans, R.M. Cell (1991) [Pubmed]
  27. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies". Grimwade, D., Biondi, A., Mozziconacci, M.J., Hagemeijer, A., Berger, R., Neat, M., Howe, K., Dastugue, N., Jansen, J., Radford-Weiss, I., Lo Coco, F., Lessard, M., Hernandez, J.M., Delabesse, E., Head, D., Liso, V., Sainty, D., Flandrin, G., Solomon, E., Birg, F., Lafage-Pochitaloff, M. Blood (2000) [Pubmed]
  28. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Gale, R.E., Hills, R., Pizzey, A.R., Kottaridis, P.D., Swirsky, D., Gilkes, A.F., Nugent, E., Mills, K.I., Wheatley, K., Solomon, E., Burnett, A.K., Linch, D.C., Grimwade, D. Blood (2005) [Pubmed]
  29. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein. Matsunaga, T., Inaba, T., Matsui, H., Okuya, M., Miyajima, A., Inukai, T., Funabiki, T., Endo, M., Look, A.T., Kurosawa, H. Blood (2004) [Pubmed]
  30. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage. Salomoni, P., Bernardi, R., Bergmann, S., Changou, A., Tuttle, S., Pandolfi, P.P. Blood (2005) [Pubmed]
  31. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C., Degos, L. Blood (1999) [Pubmed]
  32. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Morosetti, R., Park, D.J., Chumakov, A.M., Grillier, I., Shiohara, M., Gombart, A.F., Nakamaki, T., Weinberg, K., Koeffler, H.P. Blood (1997) [Pubmed]
  33. Therapy of molecular relapse in acute promyelocytic leukemia. Lo Coco, F., Diverio, D., Avvisati, G., Petti, M.C., Meloni, G., Pogliani, E.M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., Martino, B., Specchia, G., Mandelli, F. Blood (1999) [Pubmed]
  34. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Dong, S., Tweardy, D.J. Blood (2002) [Pubmed]
  35. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. Asou, N., Adachi, K., Tamura, J., Kanamaru, A., Kageyama, S., Hiraoka, A., Omoto, E., Akiyama, H., Tsubaki, K., Saito, K., Kuriyama, K., Oh, H., Kitano, K., Miyawaki, S., Takeyama, K., Yamada, O., Nishikawa, K., Takahashi, M., Matsuda, S., Ohtake, S., Suzushima, H., Emi, N., Ohno, R. J. Clin. Oncol. (1998) [Pubmed]
  36. Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RARα and PLZF/RARα with Interfering Peptides. Beez, S., Demmer, P., Puccetti, E. PLoS. One. (2012) [Pubmed]
WikiGenes - Universities